MRAM:NASDAQEverspin Technologies, Inc. Analysis
Data as of 2026-08-12 - not real-time
$17.33
Latest Price
9/10Risk
Risk Level: High
Executive Summary
At $17.33, Everspin Technologies, Inc. shows no decisive moving-average alignment, leaving the trend neutral. Over a rolling month the price has lost 23.1%. Momentum indicators put RSI at 51.1 (neutral) with MACD reading bullish. Recent trading has carved out support near $12.87 and resistance around $18.30.
On valuation the read is fair — earnings multiple of 35.4 versus a 36.3 sector average, in line with the peer group. Consensus targets land 48.1% above where the shares trade now. Revenue is growing at 41.9% on a -4.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 115.5%, a beta of 4.26 and a maximum drawdown of 70.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
On valuation the read is fair — earnings multiple of 35.4 versus a 36.3 sector average, in line with the peer group. Consensus targets land 48.1% above where the shares trade now. Revenue is growing at 41.9% on a -4.2% profit margin.
On a 1-10 scale the risk profile lands at 9 — high. With 30-day volatility of 115.5%, a beta of 4.26 and a maximum drawdown of 70.6%, position sizing matters more than entry timing here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
Short, medium and long-term reads agree on hold, with conviction of 1/10.
Top Market Events
Everspin Technologies, Inc. NASDAQ:MRAM is one of the Best Small-Cap Semiconductor Stocks to Buy Right Now. Everspin...Design And Reuse - Catalog of IP Cores and Silicon on Chip solutions for IoT, Automotive, Security, RISC-V, AI, .CHANDLER, Ariz., August 05, 2026--Everspin Technologies, Inc. NASDAQ: MRAM , the world’s leading developer and...
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 2/10
Key Factors
- Trading above the 200-day average of 14.86
- MACD momentum is positive
- 30-day price change of -23.1%
Medium Term
1–3 yearsNeutral
Model confidence: 2/10
Key Factors
- P/E of 35.4 versus sector average of 36.3
- Trading above the 200-day average of 14.86
- Analyst targets imply +48.1% versus the current price
Long Term
> 3 yearsNeutral
Model confidence: 1/10
Key Factors
- P/E of 35.4 versus sector average of 36.3
- Negative profit margin of -4.2%
- Analyst targets imply +48.1% versus the current price
Key Metrics & Analysis
Financial Health
Revenue Growth41.90%
Profit Margin-4.22%
P/E Ratio35.4
ROE-3.84%
ROA-7.21%
Debt/Equity3.88
P/B Ratio5.8
Op. Cash Flow$4.2M
Free Cash Flow$-10983250
Industry P/E36.3
Technical Analysis
TrendNeutral
RSI51.1
Support$12.87
Resistance$18.30
MA 20$15.46
MA 50$20.06
MA 200$14.86
MACDBullish
VolumeIncreasing
Fear & Greed Index94.7
Valuation
Fair Value$5.92
Target Price$25.67
Upside/Downside48.11%
GradeFair
TypeGrowth
Risk Assessment
Beta4.26
Volatility115.52%
Sector RiskHigh
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.